(Q50721761)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16862169%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

title

Loss of mammary epithelial prolactin receptor delays tumor formation by reducing cell proliferation in low-grade preinvasive lesions (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16862169%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16862169%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

James G Kench

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16862169%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

Matt Wand

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16862169%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

author name string

Robertson FG

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16862169%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

Gardiner-Garden M

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16862169%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

Green JE

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16862169%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

Ormandy CJ

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16862169%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

language of work or name

English

0 references

publication date

24 July 2006

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16862169%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16862169%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

volume

26

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16862169%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16862169%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

page(s)

543-553

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16862169%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/sj.onc.1209838

27 December 2019

exact match

0 references

cites work

Rescue of preimplantatory egg development and embryo implantation in prolactin receptor-deficient mice after progesterone administration

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209838

7 January 2021

Tamoxifen plus bromocriptine versus tamoxifen plus placebo in advanced breast cancer: results of a double blind multicentre clinical trial

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209838

7 January 2021

Wnt-4 expression induces a pregnancy-like growth pattern in reconstituted mammary glands in virgin mice.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209838

7 January 2021

Prolactin controls mammary gland development via direct and indirect mechanisms.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209838

7 January 2021

The mammary pathology of genetically engineered mice: the consensus report and recommendations from the Annapolis meeting

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209838

7 January 2021

The role of prolactin in mammary carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209838

7 January 2021

Prolactin as a mitogen in mammary cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209838

7 January 2021

Development and potential clinical uses of human prolactin receptor antagonists

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209838

7 January 2021

Antagonistic properties of human prolactin analogs that show paradoxical agonistic activity in the Nb2 bioassay

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209838

7 January 2021

The C3(1)/SV40 T-antigen transgenic mouse model of mammary cancer: ductal epithelial cell targeting with multistage progression to carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209838

7 January 2021

Endogenous human prolactin and not exogenous human prolactin induces estrogen receptor alpha and prolactin receptor expression and increases estrogen responsiveness in breast cancer cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209838

7 January 2021

Plasma sex steroid hormone levels and risk of breast cancer in postmenopausal women.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209838

7 January 2021

Plasma Prolactin Levels and Subsequent Risk of Breast Cancer in Postmenopausal Women

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209838

7 January 2021

Defective mammopoiesis, but normal hematopoiesis, in mice with a targeted disruption of the prolactin gene

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209838

7 January 2021

Transgenic mouse models of human breast cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209838

7 January 2021

Random-effects models for longitudinal data

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209838

7 January 2021

Prolactin (PRL) receptor gene expression in mouse adipose tissue: increases during lactation and in PRL-transgenic mice

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209838

7 January 2021

Human prolactin (hPRL) antagonists inhibit hPRL-activated signaling pathways involved in breast cancer cell proliferation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209838

7 January 2021

Endocrine effects of combined somatostatin analog and bromocriptine therapy in women with advanced breast cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209838

7 January 2021

Prostate and mammary adenocarcinoma in transgenic mice carrying a rat C3(1) simian virus 40 large tumor antigen fusion gene

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209838

7 January 2021

Prolactin is a local growth factor in rat mammary tumors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209838

7 January 2021

Endogenous estrogen, androgen, and progesterone concentrations and breast cancer risk among postmenopausal women

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209838

7 January 2021

RAG-1-deficient mice have no mature B and T lymphocytes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209838

7 January 2021

Prolactin regulates mammary epithelial cell proliferation via autocrine/paracrine mechanism

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209838

7 January 2021

Mouse strain-specific patterns of mammary epithelial ductal side branching are elicited by stromal factors.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209838

7 January 2021

Mammary gland development in prolactin receptor knockout mice

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209838

7 January 2021

Null mutation of the prolactin receptor gene produces multiple reproductive defects in the mouse

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209838

7 January 2021

Effect of bromocriptin treatment on prolactin and steroid receptor levels in human breast cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209838

7 January 2021

Prostate development and carcinogenesis in prolactin receptor knockout mice

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209838

7 January 2021

Prolactin induces ERalpha-positive and ERalpha-negative mammary cancer in transgenic mice

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209838

7 January 2021

Inhibition of prolactin (PRL)-induced proliferative signals in breast cancer cells by a molecular mimic of phosphorylated PRL, S179D-PRL.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209838

7 January 2021

PRL modulates cell cycle regulators in mammary tumor epithelial cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209838

7 January 2021

The C3(1)/SV40 T antigen transgenic mouse model of prostate and mammary cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209838

7 January 2021

Increased expression of prolactin receptor gene assessed by quantitative polymerase chain reaction in human breast tumors versus normal breast tissues

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209838

7 January 2021

Plasma prolactin concentrations and risk of postmenopausal breast cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209838

7 January 2021

Prolactin gene-disruption arrests mammary gland development and retards T-antigen-induced tumor growth.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209838

7 January 2021

Prolactin involvement in breast cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209838

7 January 2021

Enhancement by prolactin of carcinogen induced mammary cancerigenesis in the male rat

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209838

7 January 2021

Activation of the prolactin receptor but not the growth hormone receptor is important for induction of mammary tumors in transgenic mice.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209838

7 January 2021

The role of prolactin and growth hormone in breast cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209838

7 January 2021

Identifiers

DOI

10.1038/SJ.ONC.1209838

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16862169%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

1 reference